The modulation of TrkB via small molecule drug formulations to enhance BDNF signaling also enhanced neuronal survival in degenerating neurons in vitro (Guerzoni et al., 2017) and improved motor function and motor neuron loss in ALS model mice (Korkmaz et al., 2014). The gene discussed is BDNF; the disease is amyotrophic lateral sclerosis.